Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma

Breast Cancer Research and Treatment

Volumn 139, Issue 3, 2013, Pages 677-689

  Erin, Nuray ^a   Kale, Şule ^a   Tanrıöver, Gamze ^a   Köksoy, Sadi ^a   Duymuş, Özlem ^a   Korcum, Aylin F ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Brain metastasis; Breast cancer; Cancer stem cells; Liver metastasis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD24 ANTIGEN; CD34 ANTIGEN; HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; STROMAL CELL DERIVED FACTOR 1; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; BREAST CARCINOMA; CANCER ASSOCIATED FIBROBLAST; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HEART METASTASIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TUMOR SPHEROID;

EID: 84879798281     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2584-0     Document Type: Article

References (49)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
2. Sakorafas GH, Tsiotou AG (2000) Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Cancer Treat Rev 26:103-125
3. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275-292
4. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106:1624-1633
5. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226
6. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69:1302-1313
7. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H (2005) Prevalence of CD44 +/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11:1154-1159
8. Nathoo N, Chahlavi A, Barnett GH, Toms SA (2005) Pathobiology of brain metastases. J Clin Pathol 58:237-242
9. Patel RR, Mehta MP (2007) Targeted therapy for brain metastases: improving the therapeutic ratio. Clin Cancer Res 13:1675-1683
10. Gondi V, Mehta MP (2010) Novel insights into the management of brain metastases. Curr Opin Neurol 23:556-562
11. Tampellini M, Berruti A, Gerbino A, Buniva T, Torta M, Gorzegno G, Faggiuolo R, Cannone R, Farris A, Destefanis M, Moro G, Deltetto F, Dogliotti L (1997) Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease. Br J Cancer 75:698-702
12. Steeg PS, Theodorescu D (2008) Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5:206-219
13. Erin N, Akdas BG, Harms JF, Clawson GA (2008) Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul Pept 151:35-42
14. Erin N, Boyer PJ, Bonneau RH, Clawson GA, Welch DR (2004) Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Res 24:1003-1009
15. Erin N, Zhao W, Bylander J, Chase G, Clawson G (2006) Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells. Breast Cancer Res Treat 99:351-364
16. Erin N, Wang N, Xin P, Bui V, Weisz J, Barkan GA, Zhao W, Shearer D, Clawson GA (2009) Altered gene expression in breast cancer liver metastases. Int J Cancer 124:1503-1516
17. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52:1399-1405
18. Erin N, Duymus O, Ozturk S, Demir N (2012) Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis. Regul Pept 179:101-108
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988
20. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169-1180
21. Zoller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11:254-267
22. Sun H, Jia J, Wang X, Ma B, Di L, Song G, Ren J (2013) CD44(+)/CD24 (-) breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties. Clin Transl Oncol 15:46-54
23. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715
24. Li W, Liu F, Lei T, Xu X, Liu B, Cui L, Wei J, Guo X, Lang R, Fan Y, Gu F, Tang P, Zhang X, Fu L (2010) The clinicopathological significance of CD44 +/CD24-/low and CD24 + tumor cells in invasive micropapillary carcinoma of the breast. Pathol Res Pract 206:828-834
25. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP (2005) CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 65:10783-10793
26. Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558
27. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147:631-644
28. Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, Carcangiu ML, Passera K, Braghetti A, Scaramuzza D, Zanaboni F, Fasolo A, Capri G, Miani M, Peters WP, Gianni L (2009) Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol 20:741-745
29. Liu S, Miao Y, Fan C, Liu Y, Yu J, Zhang Y, Dai S, Wang E (2012) Clinicopathologic correlations of liver kinase B1, E-cadherin, and N-cadherin expression in non-small cell lung cancer. Appl Immunohistochem Mol Morphol
30. Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM (2003) Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63:2658-2664
31. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest PJ, Brandt B, Boecker W, Buerger H (2005) The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206:451-457
32. Ashiru O, Boutet P, Fernandez-Messina L, Aguera-Gonzalez S, Skepper JN, Vales-Gomez M, Reyburn HT (2010) Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res 70:481-489
33. Hu J, Qin K, Zhang Y, Gong J, Li N, Lv D, Xiang R, Tan X (2011) Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2 + influx in breast cancer cells. Biochem Biophys Res Commun 411:786-791
34. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi S (2000) Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 24:197-202
35. Hunt NC, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M (1997) Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 430:285-289
36. Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5:R217-R222
37. Dong HM, Liu G, Wu J, Lu JS, Luo JM, Shen ZZ, Shao ZM (2006) Biological significance of E-cadherin in an inflammatory breast carcinoma cell line. Zhonghua Zhong Liu Za Zhi 28:4-7
38. Tsuji T, Ibaragi S, Hu GF (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69:7135-7139
39. Zhang X, Hashemi SS, Yousefi M, Gao C, Sheng J, Ni J, Wang W, Mason J, Man YG (2009) Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion. Pathol Res Pract 205:375-385
40. Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A (2012) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron 5:19-28
41. Garber K (2002) Angiogenesis inhibitors suffer new setback. Nat Biotechnol 20:1067-1068
42. Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Oyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PO (2006) Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci U S A 103:16466-16471
43. Song N, Huang Y, Shi H, Yuan S, Ding Y, Song X, Fu Y, Luo Y (2009) Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Cancer Res 69:6057-6064
44. Wendel C, Hemping-Bovenkerk A, Krasnyanska J, Mees ST, Kochetkova M, Stoeppeler S, Haier J (2012) CXCR4/CXCL12 participate in extravasation of metastasizing breast cancer cells within the liver in a rat model. PLoS ONE 7:e30046
45. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64:8604-8612
46. da Silva BB, Lopes-Costa PV, dos Santos AR, de Sousa-Junior EC, Alencar AP, Pires CG, Rosal MA (2009) Comparison of three vascular endothelial markers in the evaluation of microvessel density in breast cancer. Eur J Gynaecol Oncol 30:285-288
47. Chen YT, Chen WT, Huang WT, Wu CC, Chai CY (2012) Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans. Kaohsiung J Med Sci 28:545-549
48. Takahashi RH, Matsubayashi J, Yokotsuka M, Tachibana M, Kusama H, Nagao T (2012) An intrapelvic extraintestinal gastrointestinal stromal tumor of undetermined origin: diagnosis by prostate needle biopsy. Pathol Res Pract 208:736-740
49. Mao Y, Keller ET, Garfield DH, Shen K, Wang J (2012) Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 32(1-2):303-315